Source: Journal of Clinical Oncology. Unidade: FM
Subjects: QUIMIOTERAPIA, NEOPLASIAS COLORRETAIS (COMPLICAÇÕES), DIARREIA (TERAPIA), ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOFF, Paulo M. et al. Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial. Journal of Clinical Oncology, v. 32, n. 10, p. 1006-1011, 2014Tradução . . Disponível em: https://doi.org/10.1200/JCO.2013.50.8077. Acesso em: 07 nov. 2024.APA
Hoff, P. M., Saragiotto, D. F., Barrios, C. H., Giglio, A. del, Coutinho, A. K., Andrade, A. C., et al. (2014). Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial. Journal of Clinical Oncology, 32( 10), 1006-1011. doi:10.1200/JCO.2013.50.8077NLM
Hoff PM, Saragiotto DF, Barrios CH, Giglio A del, Coutinho AK, Andrade AC, Dutra C, Forones NM, Correa M, Portella M do SO, Passos VQ, Chinen RN, Eyll B van. Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial [Internet]. Journal of Clinical Oncology. 2014 ; 32( 10): 1006-1011.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1200/JCO.2013.50.8077Vancouver
Hoff PM, Saragiotto DF, Barrios CH, Giglio A del, Coutinho AK, Andrade AC, Dutra C, Forones NM, Correa M, Portella M do SO, Passos VQ, Chinen RN, Eyll B van. Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial [Internet]. Journal of Clinical Oncology. 2014 ; 32( 10): 1006-1011.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1200/JCO.2013.50.8077
